These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8033933)

  • 1. VP-16 and the treatment of histiocytosis.
    Gadner H; Ladisch S; Aricó M; Broadbent V; Jakobson A; Komp D; Nicholson S
    Eur J Pediatr; 1994 May; 153(5):389. PubMed ID: 8033933
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: "Etoposide in the treatment of six children with Langerhans cell histiocytosis (histiocytosis X)" by Viana et al.
    Whitlock JA
    Med Pediatr Oncol; 1993; 21(5):379. PubMed ID: 8492755
    [No Abstract]   [Full Text] [Related]  

  • 3. Langerhans cell histiocytosis and etoposide: risks vs. benefits.
    D'Angio GJ
    Med Pediatr Oncol; 1994; 23(2):69-71. PubMed ID: 8202044
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk of secondary leukemia after treatment with etoposide (VP-16) for Langerhans' cell histiocytosis in Italian and Austrian-German populations.
    Haupt R; Fears TR; Heise A; Gadner H; Loiacono G; De Terlizzi M; Tucker MA
    Int J Cancer; 1997 Mar; 71(1):9-13. PubMed ID: 9096658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased risk of secondary leukemia after single-agent treatment with etoposide for Langerhans' cell histiocytosis.
    Haupt R; Fears TR; Rosso P; Colella R; Loiacono G; de Terlizzi M; Mancini A; Comelli A; Indolfi P; Donfrancesco A
    Pediatr Hematol Oncol; 1994; 11(5):499-507. PubMed ID: 7826846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute myeloid leukemia after single-agent treatment with etoposide for Langerhans' cell histiocytosis of bone.
    Haupt R; Comelli A; Rosanda C; Sessarego M; De Bernardi B
    Am J Pediatr Hematol Oncol; 1993 May; 15(2):255-7. PubMed ID: 8498650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LCH-I: a randomized trial of etoposide vs. vinblastine in disseminated Langerhans cell histiocytosis. The Histiocyte Society.
    Ladisch S; Gadner H; Aricò M; Broadbent V; Grois N; Jacobson A; Komp D; Nicholson HS
    Med Pediatr Oncol; 1994; 23(2):107-10. PubMed ID: 8202031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary acute promyelocytic leukemia after treatment with etoposide for Langerhans cell histiocytosis (LCH).
    Lopes LF; de Camargo B
    Med Pediatr Oncol; 1999 Apr; 32(4):315. PubMed ID: 10102032
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypofibrinogenemia in a girl with Langerhans cell histiocytosis during etoposide and prednisolone therapy.
    Miura T; Nakamura M; Tsunematsu Y; Fujimoto J; Meguro T; Yamada K
    Acta Paediatr Jpn; 1993 Apr; 35(2):148-50. PubMed ID: 8503273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute promyelocytic leukemia with t(15;17) abnormality after chemotherapy containing etoposide for Langerhans' cell histiocytosis.
    López-Andreu JA; Ferris J; Verdeguer A; Esquembre C; Castel V
    Cancer; 1994 Sep; 74(5):1650-2. PubMed ID: 7864932
    [No Abstract]   [Full Text] [Related]  

  • 11. Etoposide and Langerhans cell histiocytosis: second malignancies, a second look.
    Felix CA; Blatt J
    Pediatr Hematol Oncol; 1999; 16(3):183-5. PubMed ID: 10326216
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute promyelocytic leukaemia in a patient treated with etoposide for Langerhans cell histiocytosis.
    Matsuzaki A; Inamitsu T; Watanabe T; Ohga S; Ishii E; Nagotoshi Y; Tasaka H; Suda M; Ueda K
    Br J Haematol; 1994 Apr; 86(4):887-9. PubMed ID: 7918090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etoposide in Langerhans cell histiocytosis.
    Gadner H
    Pediatr Hematol Oncol; 1996; 13(4):309-11. PubMed ID: 8837135
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute promyelocytic leukemia with t(15;17) abnormality after chemotherapy containing etoposide for Langerhans cell histiocytosis.
    Horibe K; Matsushita T; Numata S; Miyajima Y; Katayama I; Kitabayashi T; Yanai M; Sekiguchi N; Egi S
    Cancer; 1993 Dec; 72(12):3723-6. PubMed ID: 8252489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of vindesine and prednisone and cyclophosphamide, etoposide, vindesine, and prednisone as first-line treatment for adult Langerhans cell histiocytosis: A single-center retrospective study.
    Duan MH; Han X; Li J; Zhang W; Zhu TN; Han B; Zhuang JL; Wang SJ; Cao XX; Cai HC; Chen M; Yang C; Zhou DB
    Leuk Res; 2016 Mar; 42():43-6. PubMed ID: 26859782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary acute myelogenous leukemia following safe exposure to etoposide.
    Stine KC; Saylors RL; Sawyer JR; Becton DL
    J Clin Oncol; 1997 Apr; 15(4):1583-6. PubMed ID: 9193356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary acute myelocytic leukemia after successful chemotherapy with etoposide for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Kitazawa J; Ito E; Arai K; Yokoyama M; Fukayama M; Imashuku S
    Med Pediatr Oncol; 2001 Aug; 37(2):153-4. PubMed ID: 11496359
    [No Abstract]   [Full Text] [Related]  

  • 18. Acquired immune deficiency, myelodysplasia, and acute nonlymphocytic leukemia associated with monosomy 7 and t(3;3) (q21;q26) in a child with Langerhans cell histiocytosis.
    Mahoney DH; McClain KL; Hanson IC; Taylor LD; Steuber CP
    Am J Pediatr Hematol Oncol; 1989; 11(2):153-7. PubMed ID: 2546462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Etoposide (VP16) treatment of Langerhans-cell histiocytosis].
    Pedrol E; Estruch R; Marrades RM; Ingelmo M
    Rev Clin Esp; 1991 Apr; 188(6):319. PubMed ID: 1780535
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment for multisystem Langerhans' cell histiocytosis.
    Katz BZ
    J Pediatr; 2002 Feb; 140(2):280. PubMed ID: 11865293
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.